During each session in this series, attendees will participate in a multidisciplinary team discussion of both prospective and follow-up case presentations. The presentations in this activity include the recommendations of the American Joint Committee on Cancer (AJCC) regarding appropriate staging in clinical practice, which includes the use of appropriate prognostic indicators and evidenced based national guidelines used in treatment planning such as NCCN, ACR, ASTRO, ASCO, and new concepts and management protocols for malignancies.  In addition, the multidisciplinary discussions will include an assessment of need for clinical trials/research, genetic counseling, nutrition, nurse navigation, social work, symptom management, palliative and hospice care, pain management, psychiatry, and oncology rehabilitation.

1. Promote a multidisciplinary and collaborative approach to the diagnosis, treatment and management of patients with hematopoietic disease.
2. Apply evidence-based medicine to ensure the most appropriate clinical pathways for enhanced patient outcomes and continuous quality improvement.
3. Advance the evaluation, treatment and management of patients through discussion of novel approaches and advanced therapies.
4. Utilize AJCC or other appropriate staging in clinical practice, which includes the use of appropriate prognostic indicators and evidence based national guidelines used in treatment planning.

Sample item